GlassScriptPhysician profile
Soo M Chung
NPI 1245293729
$992.83
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2021: $671 · 2022: $99.56.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $150.50 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $145.66 | 2019-2021 | |
| Amgen INC. | $130.77 | 2021-2022 | |
| Celgene Corporation | $65.47 | 2021 | |
| Genzyme Corporation | $58.68 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $51.13 | 2021 | |
| Pfizer INC. | $48.69 | 2021 | |
| Novartis Pharmaceuticals Corporation | $45.48 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $45.20 | 2021 | |
| Astellas Pharma US INC | $37.02 | 2021 | |
| Eisai INC. | $24.14 | 2021 | |
| Janssen Biotech, INC. | $22.74 | 2021 | |
| Incyte Corporation | $22.56 | 2021 | |
| Myriad Genetic Laboratories, INC. | $21.27 | 2021 | |
| Puma Biotechnology, INC. | $20.45 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rigel Pharmaceuticals, INC. | $20.12 | 2021 | |
| Emd Serono, INC. | $18.50 | 2021 | |
| Morphosys, US INC. | $18.14 | 2021 | |
| Global Blood Therapeutics, INC. | $16.67 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.19 | 2021 | |
| Daiichi Sankyo INC. | $13.45 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soo Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.